VEGFA and neoplasm: While their anticancer effects focus on inhibiting tumor angiogenesis which is mediated by VEGF, undesired effects can occur from anti-VEGF activity with other growth factors and receptors, including platelet-derived growth factor, fibroblast growth factor, c-Kit, and Flt-3 [6].